CSIMarket Company Name, Ticker, Competitors, else..
 
Adhera Therapeutics Inc   (ATRX)
 

ATRX's Market share relative to its competitors, as of Q2 2023

As of Q2 2023 (Revenue in Millions of $)

Date modified: 2026-08-15T07:41:03+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q2 2023		 MARKET SHARE
12 Months
Q2 2023		 MARKET SHARE
MRQ
Q2 2023		 MARKET SHARE
A Quarter Before
Q1 2023
Adhera Therapeutics Inc 2,732.01 0.79% 0.00 % 0.00 %
Eli Lilly And Company 72,249.50 20.92% 23.53% 22.48%
Abbvie Inc 62,819.00 18.19% 17.83% 19.37%
Bristol myers Squibb Company 48,482.00 14.04% 13.66% 14.57%
Amgen Inc 45,369.00 13.14% 10.24% 11.50%
Teva Pharmaceutical Industries Limited 17,350.00 5.02% 4.92% 4.64%
104 more competitors available

Sign in to see all competitors for Adhera Therapeutics Inc .

Sign In Create Free Account



ATRX's Market share relative to its competitors, as of Q2 2023 within the Major Pharmaceutical Preparations Industry
As of Q2 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
12 Months Ending
Q1 2023		 MARKET SHARE
MRQ
Q2 2023		 MARKET SHARE

Q1 2023
Adhera Therapeutics Inc 0.95% 0.30% 0.00 % 0.00 %
Eli Lilly And Company 25.18% 23.96% 27.47% 26.48%
Abbvie Inc 21.89% 22.48% 20.81% 22.81%
Bristol myers Squibb Company 16.90% 17.72% 15.94% 17.16%
Teva Pharmaceutical Industries Limited 6.05% 6.34% 5.75% 5.47%
Regeneron Pharmaceuticals Inc 5.20% 5.27% 5.00% 5.33%
100 more companies available

Sign in to see all industry competitors for Adhera Therapeutics Inc .

Sign In Create Free Account



ATRX's Market share relative to its competitors, as of Q2 2023 within the Healthcare Sector
As of Q2 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
12 Months Ending
Q1 2023		 MARKET SHARE
MRQ
Q2 2023		 MARKET SHARE

Q1 2023
Adhera Therapeutics Inc 0.79% 0.25% 0.00 % 0.00 %
Eli Lilly And Company 20.92% 20.48% 23.53% 22.48%
Abbvie Inc 18.19% 19.22% 17.83% 19.37%
Bristol myers Squibb Company 14.04% 15.15% 13.66% 14.57%
Amgen Inc 13.14% 10.50% 10.24% 11.50%
Teva Pharmaceutical Industries Limited 5.02% 5.42% 4.92% 4.64%
103 more companies available

Sign in to see all sector competitors for Adhera Therapeutics Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Adhera Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Adhera Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.